ADAMTS-13 levels in fresh, stored, and solvent detergent treated plasma

Fujikawa, 2001, Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family, Blood, 98, 1662, 10.1182/blood.V98.6.1662 Plaimauer, 2002, Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13), Blood, 100, 3626, 10.1182/blood-2002-05-1397 Furlan, 1996, Von Willebrand factor: molecular size and functional activity, Ann Hematol, 72, 341, 10.1007/s002770050184 Arya, 2002, Ultra-large multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet GP Ib-IX complex: studies using optical tweezers, Blood, 99, 3971, 10.1182/blood-2001-11-0060 Dong, 2002, ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions, Blood, 100, 4033, 10.1182/blood-2002-05-1401 Soejima, 2005, Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies, Semin Hematol, 42, 56, 10.1053/j.seminhematol.2004.09.008 Furlan, 1997, Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura, Blood, 89, 3097, 10.1182/blood.V89.9.3097 Furlan, 1998, Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the haemolytic uremic syndrome, N Engl J Med, 339, 1578, 10.1056/NEJM199811263392202 Tsai, 1998, Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura, N Engl J Med, 339, 1585, 10.1056/NEJM199811263392203 Furlan, 1998, Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura, Blood, 91, 2839, 10.1182/blood.V91.8.2839.2839_2839_2846 Rock, 1991, Comparison of plasma exchange with plasma infusion in treatment of thrombotic thrombocytopenic purpura, N Engl J Med, 325, 393, 10.1056/NEJM199108083250604 Furlan, 1996, Partial purification and characterization of protease from human plasma cleaving von Willebrand factor to fragment produced by in vivo proteolysis, Blood, 87, 4223, 10.1182/blood.V87.10.4223.bloodjournal87104223 Rick, 2004, Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS-13) and its inhibitor in a patient with thrombotic thrombocytopenic purpura, Am J Hematol, 75, 96, 10.1002/ajh.10457 Tsai, 2003, Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes, J Thromb Haemost, 1, 625, 10.1046/j.1538-7836.2003.00169.x Vermeer, 1976, Contributions to the optimal use of human blood FVIII. Stability of blood coagulation factor VIII during collection and storage of whole blood and plasma, Vox Sang, 31, 55, 10.1111/j.1423-0410.1976.tb02223.x